Identify novel antiviral drug candidates for use in treatment of pandemic-prone viral infections, including SARS-CoV-2 and future generations of coronavirus
current phase of drug development
updated 1 Mar 2022
As work to deliver a new clinical candidate can take at least two to four years, it is essential that drug discovery efforts to prepare for the next pandemic are started early. DNDi is working to contribute to pandemic preparedness through longer-term initiatives to discover novel antiviral drug candidates for the treatment of SARS-CoV-2, future generations of coronavirus, and potentially also other pandemic-prone viruses.
Get our latest news, personal stories, research articles, and job opportunities.